Marvin & Palmer Associates INC Upped Its Cme Group INC (CME) Position by $3.59 Million; Valuation Declined

November 15, 2017 - By Richard Conner

Investors sentiment decreased to 1.13 in Q2 2017. Its down 0.01, from 1.14 in 2017Q1. It turned negative, as 38 investors sold CME shares while 226 reduced holdings. 67 funds opened positions while 231 raised stakes. 268.92 million shares or 1.79% less from 273.81 million shares in 2017Q1 were reported. Td Asset Mgmt invested 0.2% of its portfolio in CME Group Inc (NASDAQ:CME). 69 are held by Alexandria Limited. Cwm Limited Liability Company, Nebraska-based fund reported 600 shares. State Bank Of Mellon invested in 5.26 million shares or 0.19% of the stock. 54,812 are owned by Marsico Management Ltd Liability Co. Laffer accumulated 24,584 shares. Bancorporation Of Nova Scotia reported 0.12% in CME Group Inc (NASDAQ:CME). Bangor Retail Bank holds 3,749 shares or 0.1% of its portfolio. Whitnell & Company accumulated 2,500 shares or 0.14% of the stock. Buckhead Capital Mgmt Llc invested 1.15% of its portfolio in CME Group Inc (NASDAQ:CME). Atria Invests Lc has invested 0.02% of its portfolio in CME Group Inc (NASDAQ:CME). Ifc Fl owns 10,071 shares or 0.1% of their US portfolio. Fukoku Mutual Life holds 2,650 shares or 0.05% of its portfolio. Cornerstone Mngmt Limited Liability Corporation owns 69,477 shares or 0.07% of their US portfolio. Voloridge Inv Management Ltd has 86,687 shares for 0.27% of their portfolio.

Since May 24, 2017, it had 0 insider buys, and 7 sales for $3.55 million activity. Sammann Derek also sold $248,298 worth of CME Group Inc (NASDAQ:CME) shares. Bitsberger Timothy S. also sold $100,744 worth of CME Group Inc (NASDAQ:CME) shares. Winkler Julie sold $539,148 worth of stock. 5,925 shares valued at $700,502 were sold by Holzrichter Julie on Wednesday, June 7. Cutinho Sunil sold $1.21 million worth of stock.

Marvin & Palmer Associates Inc increased its stake in Cme Group Inc. (CME) by 100.74% based on its latest 2017Q2 regulatory filing with the SEC. Marvin & Palmer Associates Inc bought 28,745 shares as the company’s stock declined 4.72% while stock markets rallied. The hedge fund held 57,278 shares of the investment bankers and brokers and service company at the end of 2017Q2, valued at $7.17 million, up from 28,533 at the end of the previous reported quarter. Marvin & Palmer Associates Inc who had been investing in Cme Group Inc. for a number of months, seems to be bullish on the $48.07 billion market cap company. The stock rose 0.76% or $1.06 reaching $141.26 per share. About 102,321 shares traded. CME Group Inc (NASDAQ:CME) has risen 25.35% since November 15, 2016 and is uptrending. It has outperformed by 8.65% the S&P500.

More notable recent CME Group Inc (NASDAQ:CME) news were published by: which released: “Bitcoin Surges After World’s Biggest Exchange Announces Plans for Futures” on October 31, 2017, also with their article: “TradeStation Announces Plans to Support CME Group, Inc. and Cboe Global …” published on November 13, 2017, published: “Could Bitcoin Futures Be The Catalyst To Put CME Group Over The Top?” on November 03, 2017. More interesting news about CME Group Inc (NASDAQ:CME) were released by: and their article: “CME Group flat premarket after topping estimates” published on October 26, 2017 as well as‘s news article titled: “CME Group, Inc. Announces 14% Advance In Q3 Bottom Line” with publication date: October 26, 2017.

CME Group Inc (NASDAQ:CME) Ratings Coverage

Among 15 analysts covering CME Group (NASDAQ:CME), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. CME Group had 49 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of CME Group Inc (NASDAQ:CME) earned “Buy” rating by Deutsche Bank on Wednesday, October 5. The stock of CME Group Inc (NASDAQ:CME) earned “Neutral” rating by JP Morgan on Friday, March 11. The rating was maintained by RBC Capital Markets on Monday, June 19 with “Buy”. The rating was maintained by RBC Capital Markets on Friday, October 28 with “Underperform”. Jefferies maintained it with “Buy” rating and $12800 target in Monday, July 10 report. The stock of CME Group Inc (NASDAQ:CME) earned “Neutral” rating by Sterne Agee CRT on Friday, May 20. The rating was maintained by RBC Capital Markets on Monday, June 12 with “Buy”. The rating was maintained by RBC Capital Markets with “Buy” on Monday, September 11. On Thursday, October 19 the stock rating was maintained by Citigroup with “Buy”. The firm has “Buy” rating by Deutsche Bank given on Tuesday, January 26.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.